secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2026-08-20T20:06:02+00:00
Accession:  0001801170-26-000214
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health publishes supplemental Q&A on Q2 2026 results and outlook
-----------------------------------------------------------------------

- Clover Health published a supplemental shareholder Q&A on August 20, 2026, addressing Q2 2026 results and 2026 outlook.
- The Q&A document, furnished as Exhibit 99.1, includes only an introductory letter from CEO Andrew Toy; no Q&A content is provided in the excerpt.
- No specific financial figures, guidance changes, or operational updates are disclosed in the available text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000214/0001801170-26-000214-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000214/clov-20260820.htm
  HTML page:      https://secwatch.observer/filing/0001801170-26-000214

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer